{"Q": 1, "answer": "no", "rationale": "The segment reports stock market data and a potential deal but does not contain an intensifier or comparative adjective modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_19400", "batch_size": 200, "batch_pos": 130, "statement_text": "Moderna shares climbed 2.4% premarket on Thursday after a report that the U.S. government is near a deal to fund a late-stage trial of the drugmaker's experimental mRNA bird-flu vaccine.", "article_id": 1648}
{"Q": 2, "answer": "no", "rationale": "The segment reports stock prices 'climbed' (descriptive of market trend) and a report about funding, lacking high-potency framing of the threat's impact.", "method": "llm_batch", "batch_id": "batch_2_13400", "batch_size": 200, "batch_pos": 114, "statement_text": "Moderna shares climbed 2.4% premarket on Thursday after a report that the U.S. government is near a deal to fund a late-stage trial of the drugmaker's experimental mRNA bird-flu vaccine.", "article_id": 1648}
{"Q": 3, "answer": "no", "rationale": "The segment describes financial metrics ('climbed 2.4%'), which are excluded from Q3.", "method": "llm_batch", "batch_id": "batch_3_13044", "batch_size": 200, "batch_pos": 90, "statement_text": "Moderna shares climbed 2.4% premarket on Thursday after a report that the U.S. government is near a deal to fund a late-stage trial of the drugmaker's experimental mRNA bird-flu vaccine.", "article_id": 1648}
{"Q": 4, "answer": "no", "rationale": "The segment does not contain a loaded rhetorical question.", "method": "llm_batch", "batch_id": "batch_4_14484", "batch_size": 200, "batch_pos": 88, "statement_text": "Moderna shares climbed 2.4% premarket on Thursday after a report that the U.S. government is near a deal to fund a late-stage trial of the drugmaker's experimental mRNA bird-flu vaccine.", "article_id": 1648}
{"Q": 5, "answer": "no", "rationale": "Reports stock performance and potential deal; lacks explicit calming language related to the virus.", "method": "llm_batch", "batch_id": "batch_5_1932", "batch_size": 200, "batch_pos": 84, "statement_text": "Moderna shares climbed 2.4% premarket on Thursday after a report that the U.S. government is near a deal to fund a late-stage trial of the drugmaker's experimental mRNA bird-flu vaccine.", "article_id": 1648}
{"Q": 6, "answer": "no", "rationale": "No minimiser or scale contrast found.", "method": "llm_batch", "batch_id": "batch_6_14860", "batch_size": 200, "batch_pos": 68, "statement_text": "Moderna shares climbed 2.4% premarket on Thursday after a report that the U.S. government is near a deal to fund a late-stage trial of the drugmaker's experimental mRNA bird-flu vaccine.", "article_id": 1648}
{"Q": 7, "answer": "no", "rationale": "The segment reports stock climb after a report and does not contain a bare negation.", "method": "llm_batch", "batch_id": "batch_7_6524", "batch_size": 200, "batch_pos": 65, "statement_text": "Moderna shares climbed 2.4% premarket on Thursday after a report that the U.S. government is near a deal to fund a late-stage trial of the drugmaker's experimental mRNA bird-flu vaccine.", "article_id": 1648}
{"Q": 8, "answer": "yes", "rationale": "Reports a potential deal ('is near a deal to fund') which is a future possibility/preparedness measure, without active reassurance.", "method": "llm_batch", "batch_id": "batch_8_17008", "batch_size": 200, "batch_pos": 189, "statement_text": "Moderna shares climbed 2.4% premarket on Thursday after a report that the U.S. government is near a deal to fund a late-stage trial of the drugmaker's experimental mRNA bird-flu vaccine.", "article_id": 1648}
